Vivos Therapeutics, Inc. (VVOS)

0.1428 +0.01 (+6.57%) USD  |  NASDAQ  |  Oct 15, 16:00
0.138 0.00 (0.00%) After-Hours: 07:55
More

Vivos Therapeutics Research and Development Expense (Quarterly)

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.10M
Date Value
December 31, 2023
September 30, 2023 0.10M
June 30, 2023 0.10M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Hinge Health, Inc. 34.06M
Exlites Holdings International, Inc. --
Xcelerate, Inc. --
Pro-Dex, Inc. 1.017M
Autonomix Medical, Inc. 1.515M